BridgeMD
New treatment option for Substance Use
Official title Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
ClinicalTrials.gov ID: NCT05169385
What this study is testing
- What it's testing
- Adolescents in residential substance use treatment have serious substance-related problems and poor outcomes following discharge: follow-up studies indicate that 60% of adolescents treated in residential treatment will relapse within the first 90 days. Parenting practices have been established as a critical predictor of adolescents' substance use outcomes and likelihood of relapse following treatments, but parents are notoriously difficult to engage in adolescent substance use treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 18
You may be able to join if
- for Adolescents:
- admitted to residential treatment due to concerns about frequency and/or severity of substance use
- report alcohol and/or drug use in the past 90 days
- be discharged to live with primary guardian
- fluent in English or Spanish
You likely can't join if
- for Adolescents:
- does not report alcohol or drug use in the past 90 days
- discharge plan does not include living with primary guardian
- not fluent in English or Spanish
- not willing or able to complete baseline interview Inclusion Criteria for Parents:
- parent or legal guardian of adolescent aged 12-18 years inclusive, at project start
See the full eligibility criteria
- for Adolescents:
- admitted to residential treatment due to concerns about frequency and/or severity of substance use
- report alcohol and/or drug use in the past 90 days
- be discharged to live with primary guardian
- fluent in English or Spanish
- willing and able to participate in a 2 hour interview prior to discharge from residential
- for Adolescents:
- does not report alcohol or drug use in the past 90 days
- discharge plan does not include living with primary guardian
- not fluent in English or Spanish
- not willing or able to complete baseline interview Inclusion Criteria for Parents:
- parent or legal guardian of adolescent aged 12-18 years inclusive, at project start
- adolescent admitted to residential treatment due to concerns about frequency and/or severity of substance use
- will be primary guardian living with adolescent after discharge from residential
- fluent in English or Spanish
- willing and able to complete the baseline assessment prior to the adolescent's discharge
- access to a smartphone that can receive text messages and reliably access the internet Exclusion Criteria for Parents:
- not legal guardian of adolescent or adolescent not aged between 12-18 years
- adolescent not admitted to residential treatment due to substance use concerns
- will not be living with adolescent after adolescent's discharge from residential
- not fluent in English or Spanish
- not willing or able to complete the baseline assessment prior to the adolescent's discharge
- does not have access to a smartphone that can receive text messages and reliably access the internet
The study team makes the final eligibility decision.
Where it's taking place
- Rockford, Illinois, United States
- Sioux City, Iowa, United States
- Plymouth, Minnesota, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rockford, Illinois, United States; Sioux City, Iowa, United States; Plymouth, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.